An overview of rotavirus vaccination programs in developing countries

References

• Tate JE, Burton AH, Boschi-Pinto C, et al. Global, regional, and national estimates of rotavirus mortality in children< 5 years of age, 2000–2013. Clinl Infect Dis. 2016;62(suppl_2):S96–S105.
   PubMed Web of Science ®Google Scholar
• Kirkwood CD, Ma L, Carey ME, et al. The rotavirus vaccine development pipeline. Vaccine. 2017;37(50):7328–7335.
   Web of Science ®Google Scholar
• World Health Organization. Rotavirus vaccines. Weekly Epidemiological Rec. 2007;82:285–295.
   PubMedGoogle Scholar
• Vesikari T, Matson DO, Dennehy P, et al. Safety and efficacy of a pentavalent human–bovine (WC3) reassortant rotavirus vaccine. N Engl J Med. 2006;354(1):23–33.
   PubMed Web of Science ®Google Scholar
• Ruiz-Palacios GM, Pérez-Schael I, Velázquez FR, et al. Safety and efficacy of an attenuated vaccine against severe rotavirus gastroenteritis. N Engl J Med. 2006;354(1):11–22.
   PubMed Web of Science ®Google Scholar
• Phua KB, Lim FS, Lau YL, et al. Safety and efficacy of human rotavirus vaccine during the first 2 years of life in Asian infants: randomised, double-blind, controlled study. Vaccine. 2009;27(43):5936–5941.
   PubMed Web of Science ®Google Scholar
• Madhi SA, Cunliffe NA, Steele D, et al. Effect of human rotavirus vaccine on severe diarrhea in African infants. Malawi Med J. 2016;28(3):108–114.
   PubMed Web of Science ®Google Scholar
• Zaman K, Anh DD, Victor JC, et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in Asia: a randomised, double-blind, placebo-controlled trial. Lancet. 2010;376(9741):615–623.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Rotavirus vaccines: an update. Wkly Epidemiol Rec. 2009;84(50):533–540.
   PubMedGoogle Scholar
• World Health Organization. Meeting of the immunization Strategic Advisory Group of Experts, April 2009–conclusions and recommendations. Wkly Epidemiol Rec. 2009;84(23):220–236.
   PubMedGoogle Scholar
• Tate JE, Patel MM, Cortese MM, et al. Remaining issues and challenges for rotavirus vaccine in preventing global childhood diarrheal morbidity and mortality. Expert Rev Vaccines. 2012;11(2):211–220.
   PubMed Web of Science ®Google Scholar
• Rha B, Tate JE, Weintraub E, et al. Intussusception following rotavirus vaccination: an updated review of the available evidence. Expert Rev Vaccines. 2014;13(11):1339–1348.
   PubMed Web of Science ®Google Scholar
• World Health Organization. Rotavirus vaccines: WHO position paper—January 2013. Wkly Epidemiol Rec. 2013;88(5):49–64.
   PubMedGoogle Scholar
• Weintraub ES, Baggs J, Duffy J, et al. Risk of intussusception after monovalent rotavirus vaccination. N Engl J Med. 2014;370(6):513–519.
   PubMed Web of Science ®Google Scholar
• Yen C, Tate JE, Hyde TB, et al. Rotavirus vaccines: current status and future considerations. Hum Vaccine Immunother. 2014;10(6):1436–1448.
   PubMed Web of Science ®Google Scholar
• Clark A, Tate J, Parashar U, et al. Mortality reduction benefits and intussusception risks of rotavirus vaccination in 135 low-income and middle-income countries: a modelling analysis of current and alternative schedules. Lancet Glob Health. 2019;7(11):e1541-e1552.
   PubMed Web of Science ®Google Scholar
• Aliabadi N, Antoni S, Mwenda JM, et al. Global impact of rotavirus vaccine introduction on rotavirus hospitalisations among children under 5 years of age, 2008–16: findings from the Global Rotavirus Surveillance Network. Lancet Glob Health. 2019;7(7):e893-e903.
   PubMed Web of Science ®Google Scholar
• Glass RI, Parashar U, Patel M, et al. Rotavirus vaccines: successes and challenges. J Infect. 2014;68:S9–S18.
   PubMed Web of Science ®Google Scholar
• Vesikari T. Rotavirus vaccination: a concise review. Clin Microbiol Infect. 2012;18:57–63.
   PubMed Web of Science ®Google Scholar
• Patel MM, Steele D, Gentsch JR, et al. Real-world impact of rotavirus vaccination. Pediatr Infect Dis J. 2011;30(1):S1–S5.
   PubMed Web of Science ®Google Scholar
• Madhi SA, Cunliffe NA, Steele D, et al. Effect of human rotavirus vaccine on severe diarrhea in African infants. N Engl J Med. 2010;362(4):289–298.
   PubMed Web of Science ®Google Scholar
• Armah GE, Sow SO, Breiman RF, et al. Efficacy of pentavalent rotavirus vaccine against severe rotavirus gastroenteritis in infants in developing countries in sub-Saharan Africa: a randomised, double-blind, placebo-controlled trial. Lancet. 2010;376(9741):606–614.
   PubMed Web of Science ®Google Scholar
• Patel M, Pedreira C, De Oliveira LH, et al. Effectiveness of pentavalent rotavirus vaccine against a diverse range of circulating strains in Nicaragua. Clinl Infect Dis. 2016;62(suppl_2):S127–S132.
   PubMedGoogle Scholar
• Tate JE, Ngabo F, Donnen P, et al. Effectiveness of pentavalent rotavirus vaccine under conditions of routine use in Rwanda. Clinl Infect Dis. 2016;62(suppl_2):S208–S212.
   PubMedGoogle Scholar
• Pringle KD, Patzi M, Tate JE, et al. Sustained effectiveness of rotavirus vaccine against very severe rotavirus disease through the second year of life, Bolivia 2013–2014. Clinl Infect Dis. 2016;62(suppl_2):S115–S120.
   PubMedGoogle Scholar
• Bar-Zeev N, Jere KC, Bennett A, et al. Population impact and effectiveness of monovalent rotavirus vaccination in urban Malawian children 3 years after vaccine introduction: ecological and case-control analyses. Clinl Infect Dis. 2016;62(suppl_2):S213–S219.
   PubMedGoogle Scholar
• Gheorghita S, Birca L, Donos A, et al. Impact of rotavirus vaccine introduction and vaccine effectiveness in the Republic of Moldova. Clinl Infect Dis. 2016;62(suppl_2):S140–S146.
   PubMedGoogle Scholar
• Gastañaduy PA, Steenhoff AP, Mokomane M, et al. Effectiveness of monovalent rotavirus vaccine after programmatic implementation in Botswana: a multisite prospective case-control study. Clinl Infect Dis. 2016;62(suppl_2):S161–S167.
   PubMedGoogle Scholar
• Babji S, Kang G. Rotavirus vaccination in developing countries. Curr Opin Virol. 2012;2(4):443–448.
   PubMed Web of Science ®Google Scholar
• Lamberti LM, Ashraf S, Walker CLF, et al. A systematic review of the effect of rotavirus vaccination on diarrhea outcomes among children younger than 5 years. Pediatr Infect Dis J. 2016;35(9):992–998.
   PubMed Web of Science ®Google Scholar
• Jonesteller CL, Burnett E, Yen C, et al. Effectiveness of rotavirus vaccination: a systematic review of the first decade of global postlicensure data, 2006–2016. Clinl Infect Dis. 2017;65(5):840–850.
   PubMed Web of Science ®Google Scholar
• Bhandari N, Rongsen-Chandola T, Bavdekar A, et al. Efficacy of a monovalent human-bovine (116E) rotavirus vaccine in Indian infants: a randomised, double-blind, placebo-controlled trial. Lancet. 2014;383(9935):2136–2143.
   PubMed Web of Science ®Google Scholar
• Kulkarni PS, Desai S, Tewari T, et al. A randomized Phase III clinical trial to assess the efficacy of a bovine-human reassortant pentavalent rotavirus vaccine in Indian infants. Vaccine. 2017;35(45):6228–6237.
   PubMed Web of Science ®Google Scholar
• Isanaka S, Guindo O, Langendorf C, et al. Efficacy of a low-cost, heat-stable oral rotavirus vaccine in Niger. N Engl J Med. 2017;376(12):1121–1130.
   PubMed Web of Science ®Google Scholar
• Correia JB, Patel M, Nakagomi O, et al. Effectiveness of monovalent rotavirus vaccine (Rotarix) against severe diarrhea caused by serotypically unrelated G2P [4] Strains in Brazil. J Infect Dis. 2010;201(3):363–369.
   PubMed Web of Science ®Google Scholar
• de Palma O, Cruz L, Ramos H, et al. Effectiveness of rotavirus vaccination against childhood diarrhoea in El Salvador: case-control study. BMJ. 2010;340:c2825.
   PubMed Web of Science ®Google Scholar
• Justino MCA, Linhares AC, Lanzieri TM, et al. Effectiveness of the monovalent G1P [8] human rotavirus vaccine against hospitalization for severe G2P [4] rotavirus gastroenteritis in Belém, Brazil. Pediatr Infect Dis J. 2011;30(5):396–401.
   PubMed Web of Science ®Google Scholar
• Clark A, van Zandvoort K, Flasche S, et al. Efficacy of live oral rotavirus vaccines by duration of follow-up: a meta-regression of randomised controlled trials. Lancet Infect Dis. 2019;19(7):717–727.
   Web of Science ®Google Scholar
• Qadri F, Bhuiyan TR, Sack DA, et al. Immune responses and protection in children in developing countries induced by oral vaccines. Vaccine. 2013;31(3):452–460.
   PubMed Web of Science ®Google Scholar
• Parashar UD, Johnson H, Steele AD, et al. Health impact of rotavirus vaccination in developing countries: progress and way forward. Clinl Infect Dis. 2016;62(suppl_2):S91–S95.
   PubMedGoogle Scholar
• Bhaskaram P, Nair KM, Hemalatha P, et al. Systemic and mucosal immune response to polio vaccination with additional dose in newborn period. J Trop Pediatr. 1997;43(4):232–234.
   PubMed Web of Science ®Google Scholar
• Albert MJ, Qadri F, Wahed M, et al. Supplementation with zinc, but not vitamin A, improves seroconversion to vibriocidal antibody in children given an oral cholera vaccine. J Infect Dis. 2003;187(6):909–913.
   PubMed Web of Science ®Google Scholar
• Ali A, Kazi AM, Cortese MM, et al. Impact of withholding breastfeeding at the time of vaccination on the immunogenicity of oral rotavirus vaccine—a randomized trial. PLoS One. 2015;10(6):e0127622.
   PubMed Web of Science ®Google Scholar
• Lazarus RP, John J, Shanmugasundaram E, et al. The effect of probiotics and zinc supplementation on the immune response to oral rotavirus vaccine: a randomized, factorial design, placebo-controlled study among Indian infants. Vaccine. 2018;36(2):273–279.
   PubMed Web of Science ®Google Scholar
• Steele A, De Vos B, Tumbo J, et al. Co-administration study in South African infants of a live-attenuated oral human rotavirus vaccine (RIX4414) and poliovirus vaccines. Vaccine. 2010;28(39):6542–6548.
   PubMed Web of Science ®Google Scholar
• Ramani S, Mamani N, Villena R, et al. Rotavirus serum IgA immune response in children receiving rotarix coadministered with bOPV or IPV. Pediatr Infect Dis J. 2016;35(10):1137–1139.
   PubMed Web of Science ®Google Scholar
• Cherian T, Wang S, Mantel C. Rotavirus vaccines in developing countries: the potential impact, implementation challenges, and remaining questions. Vaccine. 2012;30:A3–A6.
   PubMed Web of Science ®Google Scholar
• Emperador DM, Velasquez DE, Estivariz CF, et al. Interference of monovalent, bivalent, and trivalent oral poliovirus vaccines on monovalent rotavirus vaccine immunogenicity in rural Bangladesh. Clinl Infect Dis. 2015;62(2):150–156.
   PubMed Web of Science ®Google Scholar
• Steele AD, Victor JC, Carey ME, et al. Experiences with rotavirus vaccines: can we improve rotavirus vaccine impact in developing countries? Hum Vaccin Immunother. 2019;15(6):1215–1227.
   PubMed Web of Science ®Google Scholar
• Burnett E, Jonesteller CL, Tate JE, et al. Global impact of rotavirus vaccination on childhood hospitalizations and mortality from diarrhea. J Infect Dis. 2017;215(11):1666–1672.
   PubMed Web of Science ®Google Scholar
• Chavers T, De Oliveira LH, Parashar UD, et al. Post-licensure experience with rotavirus vaccination in Latin America and the Caribbean: a systematic review and meta-analysis. Expert Rev Vaccines. 2018;17(11):1037–1051.
   PubMed Web of Science ®Google Scholar
• Shah MP, Tate JE, Mwenda JM, et al. Estimated reductions in hospitalizations and deaths from childhood diarrhea following implementation of rotavirus vaccination in Africa. Expert Rev Vaccines. 2017;16(10):987–995.
   PubMed Web of Science ®Google Scholar
• Mwenda JM, Parashar UD, Cohen AL, et al. Impact of rotavirus vaccines in Sub-Saharan African countries. 2018;36(47):7119–7123.
   Google Scholar
• Karafillakis E, Hassounah S, Atchison C. Effectiveness and impact of rotavirus vaccines in Europe, 2006-2014. Vaccine. 2015;33(18):2097–2107.
   PubMed Web of Science ®Google Scholar
• Sahakyan G, et al. Impact and effectiveness of monovalent rotavirus vaccine in Armenian children. Clinl Infect Dis. 2016;62(suppl_2):S147–S154.
   PubMedGoogle Scholar
• Burnett E, Tate JE, Kirkwood CD, et al. Estimated impact of rotavirus vaccine on hospitalizations and deaths from rotavirus diarrhea among children <5 in Asia. Expert Rev Vaccines. 2018;17(5):453–460.
   PubMed Web of Science ®Google Scholar
• Tate JE, Steele AD, Bines JE, et al. Research priorities regarding rotavirus vaccine and intussusception: a meeting summary. Vaccine. 2012;30:A179–A184.
   PubMed Web of Science ®Google Scholar
• Patel MM, López-Collada VR, Bulhões MM, et al. Intussusception risk and health benefits of rotavirus vaccination in Mexico and Brazil. N Engl J Med. 2011;364(24):2283–2292.
   PubMed Web of Science ®Google Scholar
• Buttery J, Danchin MH, Lee KJ, et al. Intussusception following rotavirus vaccine administration: post-marketing surveillance in the National Immunization Program in Australia. Vaccine. 2011;29(16):3061–3066.
   PubMed Web of Science ®Google Scholar
• Lopman BA, Payne DC, Tate JE, et al. Post-licensure experience with rotavirus vaccination in high and middle income countries; 2006 to 2011. Curr Opin Virol. 2012;2(4):434–442.
   PubMed Web of Science ®Google Scholar
• Australian Government Therapeutic Goods Administration. Rotavirus vaccination and the risk of intussusception. 2013 Dec 16 [ 2019]; [cited 2019 Dec 15]. Available from: https://www.tga.gov.au/alert/rotavirus-vaccination-and-risk-intussusception-0
   Google Scholar
• Cortese MM. Summary of intussusception risk and benefits of rotavirus vaccination in the United States. Centers for Disease Control and Prevention Advisory Committee on Immunization Practices, 20 June 2013. 2014.
   Google Scholar
• Clark A, Jit M, Andrews N, et al. Evaluating the potential risks and benefits of infant rotavirus vaccination in England. Vaccine. 2014;32(29):3604–3610.
   PubMed Web of Science ®Google Scholar
• Tate JE, Mwenda JM, Armah G, et al. Evaluation of intussusception after monovalent rotavirus vaccination in Africa. N Engl J Med. 2018;378(16):1521–1528.
   PubMed Web of Science ®Google Scholar
• Groome MJ, et al. Evaluation of intussusception after oral monovalent rotavirus vaccination in South Africa. Clinl Infect Dis. 2020;70(8):1606-1612.
   Web of Science ®Google Scholar
• Rheingans RD, Antil L, Dreibelbis R, et al. Economic costs of rotavirus gastroenteritis and cost-effectiveness of vaccination in developing countries. J Infect Dis. 2009;200(Supplement_1):S16–S27.
   PubMedGoogle Scholar
• Debellut F, Clark A, Pecenka C, et al. Re-evaluating the potential impact and cost-effectiveness of rotavirus vaccination in 73 Gavi countries: a modelling study. Lancet Glob Health. 2019;7(12):e1664-e1674.
   PubMed Web of Science ®Google Scholar
• Tate JE, Parashar UD. Rotavirus vaccines in routine use. Clinl Infect Dis. 2014;59(9):1291–1301.
   PubMed Web of Science ®Google Scholar
• Makinen M, Kaddar M, Molldrem, V, et al. New vaccine adoption in lower-middle-income countries. Health Policy. 2012;27(suppl_2):ii39–ii49.
   Google Scholar
• De Oliveira LH, Danovaro-Holliday MC, Matus CR, et al. Rotavirus vaccine introduction in the Americas: progress and lessons learned. Expert Rev Vaccines. 2008;7(3):345–353.
   PubMed Web of Science ®Google Scholar
• Groome MJ, Zell ER, Solomon F, et al. Temporal association of rotavirus vaccine introduction and reduction in all-cause childhood diarrheal hospitalizations in South Africa. Clinl Infect Dis. 2016;62(suppl_2):S188–S195.
   PubMedGoogle Scholar
• Mpabalwani EM, Simwaka CJ, Mwenda JM, et al. Impact of rotavirus vaccination on diarrheal hospitalizations in children aged< 5 years in Lusaka, Zambia. Clinl Infect Dis. 2016;62(suppl_2):S183–S187.
   PubMedGoogle Scholar
• Moon S, Wang Y, Edens C, et al. Dose sparing and enhanced immunogenicity of inactivated rotavirus vaccine administered by skin vaccination using a microneedle patch. Vaccine. 2013;31(34):3396–3402.
   PubMed Web of Science ®Google Scholar
• Burke RM, et al. Current and new rotavirus vaccines. Current opinion in infectious diseases. 2019;32(5):435.
   Google Scholar